iRhythm Technologies (IRTC) Competitors

iRhythm Technologies (NASDAQ:IRTC) and Smith & Nephew (NYSE:SNN) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, risk, community ranking, media sentiment, valuation, institutional ownership, profitability, analyst recommendations and dividends.

Which has more risk and volatility, IRTC or SNN?

iRhythm Technologies has a beta of 1.45, suggesting that its stock price is 45% more volatile than the S&P 500. Comparatively, Smith & Nephew has a beta of 0.71, suggesting that its stock price is 29% less volatile than the S&P 500.

Does the MarketBeat Community prefer IRTC or SNN?

Smith & Nephew received 40 more outperform votes than iRhythm Technologies when rated by MarketBeat users. However, 66.07% of users gave iRhythm Technologies an outperform vote while only 54.16% of users gave Smith & Nephew an outperform vote.

Company	Underperform	Outperform
iRhythm Technologies	Outperform Votes 409 66.07%	Underperform Votes 210 33.93%
Smith & Nephew	Outperform Votes 449 54.16%	Underperform Votes 380 45.84%

Do insiders and institutionals hold more shares of IRTC or SNN?

25.6% of Smith & Nephew shares are owned by institutional investors. 0.7% of iRhythm Technologies shares are owned by insiders. Comparatively, 1.0% of Smith & Nephew shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Is IRTC or SNN more profitable?

Smith & Nephew has a net margin of 0.00% compared to iRhythm Technologies' net margin of -19.14%. Smith & Nephew's return on equity of 0.00% beat iRhythm Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
iRhythm Technologies	-19.14%	-118.83%	-11.34%
Smith & Nephew	N/A	N/A	N/A

Do analysts prefer IRTC or SNN?

iRhythm Technologies presently has a consensus target price of $119.73, indicating a potential upside of 12.01%. Smith & Nephew has a consensus target price of $27.00, indicating a potential downside of 3.57%. Given iRhythm Technologies' stronger consensus rating and higher possible upside, analysts clearly believe iRhythm Technologies is more favorable than Smith & Nephew.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iRhythm Technologies	0 Sell rating(s)	2 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.82
Smith & Nephew	0 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Does the media prefer IRTC or SNN?

In the previous week, iRhythm Technologies had 6 more articles in the media than Smith & Nephew. MarketBeat recorded 15 mentions for iRhythm Technologies and 9 mentions for Smith & Nephew. iRhythm Technologies' average media sentiment score of 0.99 beat Smith & Nephew's score of 0.86 indicating that iRhythm Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
iRhythm Technologies	8 Very Positive mention(s)	0 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Smith & Nephew	5 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has better earnings & valuation, IRTC or SNN?

Smith & Nephew has higher revenue and earnings than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than Smith & Nephew, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iRhythm Technologies	$591.84M	5.76	-$123.41M	-$3.64	-29.37
Smith & Nephew	$5.81B	2.11	$263M	$2.16	12.96

Summary

Smith & Nephew beats iRhythm Technologies on 10 of the 18 factors compared between the two stocks.